恒益舒棠

Anhui Hengyi Pharmaceutical, a subsidiary of the CSPC Pharmaceutical Group, is a prominent Chinese pharmaceutical manufacturer based in Xuancheng, Anhui Province. The company specializes in the development and production of finished dosage forms, with a strong focus on metabolic diseases, cardiovascular health, and anti-infectives. Its most recognizable brand, Shutang (Sitagliptin Phosphate), is a leading DPP-4 inhibitor used in the management of type 2 diabetes within the Chinese market. Operating from large-scale, GMP-certified facilities, Anhui Hengyi integrates research, production, and sales to support CSPC's broader strategic goals. The company's portfolio includes a wide range of essential medicines, including antihypertensives and antibiotics, making it a key player in China's domestic healthcare supply chain.